Evidence map›Paper›PMID 33816884›Full record

ArticlePeerJ. Computer science2019

Blind normalization of public high-throughput databases.

Sebastian Ohse, Melanie Boerries, Hauke Busch

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebastian OhseInstitute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.
Melanie Boerries *German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hauke Busch *Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of high-throughput technologies in the domain of molecular and cell biology, as well as medicine, has generated an unprecedented amount of quantitative high-dimensional data. Public databases at present make a wealth of this data available, but appropriate normalization is critical for meaningful analyses integrating different experiments and technologies. Without such normalization, meta-analyses can be difficult to perform and the potential to address shortcomings in experimental designs, such as inadequate replicates or controls with public data, is limited. Because of a lack of quantitative standards and insufficient annotation, large scale normalization across entire databases is currently limited to approaches that demand ad hoc assumptions about noise sources and the biological signal. By leveraging detectable redundancies in public databases, such as related samples and features, we show that blind normalization without constraints on noise sources and the biological signal is possible. The inherent recovery of confounding factors is formulated in the theoretical framework of compressed sensing and employs efficient optimization on manifolds. As public databases increase in size and offer more detectable redundancies, the proposed approach is able to scale to more complex confounding factors. In addition, the approach accounts for missing values and can incorporate spike-in controls. Our work presents a systematic approach to the blind normalization of public high-throughput databases.

Indexed as

Blind normalizationCompressed sensingConfounding factorsHigh-throughput data

Identifiers

PMID33816884
PMCPMC7924423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.